ArticleJCO global oncology2021
Cervical Cancer-Associated Suffering: Estimating the Palliative Care Needs of a Highly Vulnerable Population.
Article in JCO global oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.
- Access to palliative care in patients with advanced cancer of the uterine cervix in the low- and middle-income countries: a systematic review.BMC palliative care · 2023Pooled it
- European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023Guideline
- Determinants of precancerous cervical lesion among HIV positive women on ART in Awi zone public health facilities, Northwest Ethiopia, 2024.Scientific reports · 2026Article
- Challenges to human papillomavirus vaccination among young girls in Morocco: A national cross-sectional study.PloS one · 2026Article
- Predictors of significant distress in cervical cancer patients: a cross sectional study.Archives of gynecology and obstetrics · 2024Article
- Palliative and end-of-life care initiatives for people dying from cancer in India: a narrative review.Ecancermedicalscience · 2024Review
- Editorial: Cervical cancer: updates from the Mexican national consensus.Frontiers in oncology · 2024Article
- Pain management in cervical cancer.Frontiers in oncology · 2024Review
- Article
- Frequency and duration of suffering of cervical cancer patients and caregivers: Results from an international Delphi study.PLOS global public health · 2023Article
- Temporal trends and barriers for inpatient palliative care referral in metastatic gynecologic cancer patients receiving specific critical care therapies.Frontiers in oncology · 2023Article
- The state of gynecologic radiation therapy in low- and middle-income countries.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2022Review
- Increasing global accessibility to high-level treatments for cervical cancers.Gynecologic oncology · 2022Review
- Cervical Cancer: 90-70-90 and Palliative Care.JCO global oncology · 2021Article
- Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population.JCO global oncology · 2021Article
- Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering.JCO global oncology · 2021Article
Corrections and comments
- Commented on by
Authors and funding
29 authors at 18 institutions in 14 countries.
Funding
Abstract
purposeTo enable design of optimum palliative care for women with cervical cancer, we studied the most common types of suffering and their severity, prevalence, and duration.
methodsWe first reviewed the literature on the major types, severity, prevalence, and duration of suffering associated with cervical cancer. We then conducted a modified Delphi process with experts in cervical cancer care to supplement the literature. For each type of suffering, we distinguished between decedents (those who die from cervical cancer in a given year) and nondecedents (those who have cervical cancer in a given year but do not die). By applying the suffering prevalence and duration estimates to the number of decedents, nondecedents, and family caregivers in 2017, we were able to estimate their palliative care needs and the intensity of palliative care needed to respond adequately to this suffering.
resultsThere is a high prevalence among decedents of moderate or severe pain (84%), vaginal discharge (66%), vaginal bleeding (61%), and loss of faith (31%). Among both decedents and nondecedents, there is a high prevalence of clinically significant anxiety (63% and 50%, respectively), depressed mood (52% and 38%, respectively), and sexual dysfunction (87% and 83%, respectively). Moderate or severe financial distress is prevalent among decedents, nondecedents, and family caregivers (84%, 74%, and 66%, respectively). More than 40% of decedents and nondecedents are abandoned by their intimate partners. Most patients experience some combination of moderate or severe physical, psychological, social, and spiritual suffering. In total, 258,649 decedents and 2,558,857 nondecedents needed palliative care in 2017, approximately 85% of whom were in low- and middle-income countries where palliative care is rarely accessible.
conclusionAmong women with advanced cervical cancer, suffering is highly prevalent and often severe and multifaceted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.